A critical breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage dysfunctional p53. This essential tumor protector protein is frequently disabled in several kinds of https://tetrabookmarks.com/story21977657/mini-antibodies-reactivate-p53-the-potential-hope-for-cancer-therapy